PI 103,
PI-103,
PI103,
PI-103,
371935-74-9,
PI103,
3-(4-morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol,
UNII-YQX02F616F,
PI 103,
PIK-103,
Phenol, 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]-,
YQX02F616F,
CHEBI:90524,
AK163162,
3-[4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol,
3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol,
3-(4-(4-Morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol,
3-(4-Morpholin-4-Ylpyrido[3',2':4,5]furo[3,2-D]pyrimidin-2-Yl)phenol,
Phenol, 3-(4-(4-morpholinyl)pyrido(3',2':4,5)furo(3,2-d)pyrimidin-2-yl)-,
3-(4-(4-Morpholinyl)pyrido[3′,2′:4,5]furo[3,2-d]pyrimidin-2-yl)phenol,
3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2,4,6,9,11-hexaen-4-yl]phenol,
X6K,
PI 103 hydrobromide,
Kinome_3597,
2x6k,
cc-5,
mTOR Inhibitor, PI103,
MLS006010988,
SCHEMBL258242,
CHEMBL573339,
GTPL5701,
BDBM25045,
cid_9884685,
CTK8F1083,
KS-00000HCH,
DTXSID40190676,
EX-A039,
PIK 103,
QCR-256,
SYN1065,
4l23,
pyridofuropyrimidine derivative, 2,
TUVCWJQQGGETHL-UHFFFAOYSA-N,
BCPP000107,
HMS3229C15,
HMS3244E11,
HMS3244E12,
HMS3244F11,
HMS3650M10,
HMS3654E09,
BCP01923,
BCP19373,
ZINC3963016,
IN1151,
MFCD11983145,
RS0078,
s1038,
AKOS024462563,
CCG-101301,
compound 2 [PMID: 17601739],
CS-0127,
NCGC00187906-01,
NCGC00187906-02,
NCGC00187906-03,
AS-16221,
BC660046,
HY-10115,
PI - 103,
SMR002530603,
AB0033724,
RT-015051,
FT-0712341,
SW218117-2,
X7432,
EC-000.2123,
W-5518,
935P749,
SR-01000946304,
SR-01000946304-1,
BRD-K67868012-003-01-5,
3-(4-morpholinopyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol,
3-[4-(4-morpholinyl)-2-pyrido[2,3]furo[2,4-b]pyrimidinyl]phenol,
3-(4-(4-morpholinyl)pyrido[3?,2?:4,5]furo[3,2-d]pyrimidin-2- yl)phenol,
3-(4-morpholin-4-ylpyrido[3 ,2 :4,5]furo[3,2-d]pyrimidin-2-yl)phenol,
3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl],
3-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol,
3-[4-(4-MORPHOLINYLPYRIDO)[3,2:4,5]FURO[3,2-D]PYRIMIDIN-2-YL]PHENOL HYDROCHLORIDE,
3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl]phenol,
3-[6-(morpholin-4-yl)-8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2,4,6,10,12-hexaen-4-yl]phenol,
PI-103 hydrobromide,
D0W8XH,
PI 103 HYDROCHLORIDE,
CHEMBL538346,
C19H16N4O3,
CM0174,
CID9884685,
CID 9884685,
A2067,
A10726,
C522973,
3-(4-Morpholinopyrido[3',2':4,5],,,,,,,,,,,,,,,,,
PI-103, 98%, a potent PI3K/Akt and mTOR inhibitor - 10MG 10mg,
3-[4-(4-Morpholinylpyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol,